TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,972,636 | +410.0% | 1,032,491 | +417.9% | 0.00% | – |
| Q2 2023 | $3,132,181 | -30.8% | 199,375 | -27.4% | 0.00% | – |
| Q1 2023 | $4,524,024 | -17.6% | 274,516 | -22.0% | 0.00% | -100.0% |
| Q4 2022 | $5,493,431 | -56.2% | 352,143 | -63.6% | 0.00% | -50.0% |
| Q3 2022 | $12,552,000 | +31.6% | 967,725 | +42.5% | 0.00% | 0.0% |
| Q2 2022 | $9,535,000 | +1.3% | 679,166 | +3.3% | 0.00% | 0.0% |
| Q1 2022 | $9,417,000 | -29.0% | 657,583 | -32.5% | 0.00% | -33.3% |
| Q4 2021 | $13,269,000 | -17.7% | 973,518 | -1.1% | 0.00% | 0.0% |
| Q3 2021 | $16,120,000 | +10.0% | 984,078 | +13.0% | 0.00% | 0.0% |
| Q2 2021 | $14,652,000 | -30.8% | 870,590 | -24.9% | 0.00% | -40.0% |
| Q1 2021 | $21,162,000 | -2.8% | 1,158,878 | -3.1% | 0.01% | -16.7% |
| Q4 2020 | $21,776,000 | +3.2% | 1,196,448 | +1.1% | 0.01% | -14.3% |
| Q3 2020 | $21,106,000 | -5.0% | 1,183,097 | -4.5% | 0.01% | -12.5% |
| Q2 2020 | $22,216,000 | +9.2% | 1,239,103 | -7.5% | 0.01% | 0.0% |
| Q1 2020 | $20,340,000 | -30.0% | 1,339,837 | -9.1% | 0.01% | -38.5% |
| Q4 2019 | $29,076,000 | +8.1% | 1,473,683 | -5.8% | 0.01% | 0.0% |
| Q3 2019 | $26,904,000 | +0.4% | 1,564,194 | +3.3% | 0.01% | +8.3% |
| Q2 2019 | $26,795,000 | +145.4% | 1,513,806 | +182.4% | 0.01% | +200.0% |
| Q1 2019 | $10,917,000 | +12.5% | 535,978 | -7.1% | 0.00% | -20.0% |
| Q4 2018 | $9,706,000 | – | 577,084 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |